At NYU Langone, I care for women with complex urologic issues that require reconstruction of the urinary tract, such as pelvic organ prolapse, urinary incontinence, and overactive bladder. I treat men with urinary incontinence, lower urinary tract symptoms, and benign prostatic enlargement, as well as men and women with neurogenic voiding dysfunction.
In more than two decades as a urologist dedicated to treating people with conditions that affect their quality of life, I have come to realize the importance of understanding how a condition affects a given patient. A big part of this is understanding what each patient expects from treatment.
At NYU Langone, we take a patient-centered and individualized approach to treatment. We don’t just focus on managing people’s conditions—we aim to improve quality of life. One of the ways in which we do this is by combining the expertise of different specialists.
At the Center for Female Pelvic Medicine, urologists and gynecologists work together to care for people with complex pelvic health problems. This collaborative approach between physicians from different specialties—all board certified in female pelvic medicine—better equips all of us to manage any condition, whether it’s more of a urologic or gynecologic concern.
To treat people in a way that focuses on improving their quality of life, I first have to understand their expectations about treatment. I listen to my patients and then offer them the treatment options we believe are best suited to manage the condition and meet their treatment goals.
At NYU Langone, we have contributed to advancements in urology and pelvic medicine. We pioneered the use of botulinum toxin, or Botox®, injections for the treatment of overactive bladder and urinary incontinence. We have also researched the management of different types of voiding dysfunction and are developing advanced surgical procedures for pelvic organ prolapse and urinary incontinence.
I have dedicated part of my life to training the medical leaders of tomorrow. I currently serve as the chair of education for the American Urological Association. At NYU School of Medicine, I educate future physicians, helping to ensure that patients always receive the best quality and most innovative care at NYU Langone.
Conditions and Treatments
Show More Conditions
- Professor, Department of Urology
- Professor, Department of Obstetrics and Gynecology
- Director, Female Pelvic Medicine and Reconstructive Surgery Program
- Vice Chair, Department of Urology
- Director, Female Pelvic Medicine Fellowship Program
- American Board of Urology (Female Pelvic Medicine and Reconstruction), 2013
- American Board of Urology - Urology, 1994
Education and Training
- Fellowship, University of California, Urogynecology, 1992
- Residency, SUNY Downstate Medical Center, Urology, 1991
- Residency, SUNY Downstate Medical Center, Surgery, 1987
- MD from UMDNJ, 1985
Locations and Appointments
- Cigna EPO/POS
- Cigna PPO
- Empire Blue Cross Blue Shield EPO
- Empire Blue Cross Blue Shield HMO
- Empire Blue Cross Blue Shield Indemnity
- Empire Blue Cross Blue Shield MediBlue
- Empire Blue Cross Blue Shield POS
- Empire Blue Cross Blue Shield PPO
- Empire Blue Cross Blue Shield Pathways, Enhanced
- HealthSmart (WTC)
- Hotel Trades
- MagnaCare PPO
- MultiPlan/PHCS PPO
- NYS Empire Plan
- Oxford Freedom
- Oxford Liberty
- Oxford Medicare
- Railroad Medicare
- UnitedHealthcare Community & State Plan
- UnitedHealthcare Core and Charter
- UnitedHealthcare EPO
- UnitedHealthcare HMO
- UnitedHealthcare Medicare
- UnitedHealthcare POS
- UnitedHealthcare PPO
- UnitedHealthcare Top Tier
NYU Lutheran Associates - Medical Arts Pavilion
8714 5th Ave
Brooklyn, NY 11209
NYU Lutheran Associates
150 55th Street
Brooklyn, NY 11220
HOW USEFUL ARE URODYNAMICS IN THE PREOPERATIVE ASSESSMENT OF WOMEN UNDER GOING SURGERY FOR PELVIC ORGAN PROLAPSE? [Meeting Abstract]
Glass, Dianne; Khan, Aqsa; Seo, Lauren; Brucker, Benjamin; Nitti, Victor
Neurourology & urodynamics. 2016 FEB. 35: S96-S96
Female Bladder Outlet Obstruction
Hoffman, Daniel S; Nitti, Victor W
Current urology reports. 2016 Apr . 17 (4): 31-31
Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study
Nitti, Victor W; Ginsberg, David; Sievert, Karl-Dietrich; Sussman, David; Radomski, Sidney; Sand, Peter; De Ridder, Dirk; Jenkins, Brenda; Magyar, Andrew; Chapple, Christopher
Journal of urology. 2016 Mar 30. ?-?